MECOMED CEO Visits Healthcare+ Expo Taiwan, Explores Taiwan Collaboration to Boost Digital Health and Local Manufacturing in MENA

📣Unlock New MedTech Partnerships in Asia!
【2025 Registration Opens Now ▸ https://ibmi.pse.is/7mn2dd 】

Middle East and North Africa (MENA)’s healthcare sector is experiencing unprecedented growth, particularly in digital health and innovative technologies, driven by surging demand. The region’s digital health market reached $10.98 billion in 2022 and is projected to expand at a 19.6% compound annual growth rate. With governments actively pursuing local manufacturing opportunities, there is rising interest in internationally certified medical products (e.g., CE marks, FDA approvals).

Rami Rajab, CEO of the Middle East and Africa Medical Devices and Diagnostics Trade Association (MECOMED), highlighted the significant opportunities within the MENA medical device market for Taiwanese companies and to explore potential collaborations.

Targeting this momentum, Rami Rajab, CEO of the Middle East and Africa Medical Devices and Diagnostics Trade Association (MECOMED), visited Taiwan during the 2024 Healthcare+ Expo Taiwan to explore the latest advancements in digital health and medical devices. He aimed to identify Taiwanese innovators who possess international certifications and technical expertise to collaborate on market expansion and local manufacturing opportunities in the region.

“Taiwan’s MedTech holds immense potential for our markets,” Rajab emphasized. Compared to mature markets like Europe and the U.S., MENA regions offer greater pricing flexibility and more accommodating regulatory environments, simplifying market entry. He advised Taiwanese firms to engage MECOMED early to leverage its networks for partner matchmaking and regulatory navigation.

At the 2024 Healthcare+ Expo Taiwan, Rami Rajab observed various advanced medical technologies, innovative digital health solutions, and the strong potential for international partnerships presented by Taiwanese exhibitors.


Rajab singled out Saudi Arabia as a priority market under its “Vision 2030” initiative, which incentivizes foreign manufacturers to establish local operations. The Saudi Food and Drug Authority (SFDA) has streamlined certification and factory setup processes for innovative medical devices. “Local production in Saudi Arabia not only secures government contracts but also positions companies to export regionally,” he noted.